company background image
RNO

Rhinomed ASX:RNO Stock Report

Last Price

AU$0.095

Market Cap

AU$27.1m

7D

-13.6%

1Y

-63.5%

Updated

03 Feb, 2023

Data

Company Financials

RNO Stock Overview

Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide.

RNO fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

My Notes

New

Notes are coming soon

Rhinomed Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Rhinomed
Historical stock prices
Current Share PriceAU$0.095
52 Week HighAU$0.27
52 Week LowAU$0.095
Beta0.88
1 Month Change-17.39%
3 Month Change-20.83%
1 Year Change-63.46%
3 Year Change-40.63%
5 Year Change-20.83%
Change since IPO-98.59%

Recent News & Updates

Recent updates

Rhinomed (ASX:RNO) Is In A Strong Position To Grow Its Business

Mar 01
Rhinomed (ASX:RNO) Is In A Strong Position To Grow Its Business

Here's Why We're Not Too Worried About Rhinomed's (ASX:RNO) Cash Burn Situation

Jul 09
Here's Why We're Not Too Worried About Rhinomed's (ASX:RNO) Cash Burn Situation

Here's Why We're Watching Rhinomed's (ASX:RNO) Cash Burn Situation

Mar 01
Here's Why We're Watching Rhinomed's (ASX:RNO) Cash Burn Situation

Key Things To Understand About Rhinomed's (ASX:RNO) CEO Pay Cheque

Jan 25
Key Things To Understand About Rhinomed's (ASX:RNO) CEO Pay Cheque

How Many Rhinomed Limited (ASX:RNO) Shares Did Insiders Buy, In The Last Year?

Dec 20
How Many Rhinomed Limited (ASX:RNO) Shares Did Insiders Buy, In The Last Year?

Shareholder Returns

RNOAU PharmaceuticalsAU Market
7D-13.6%-3.6%0.8%
1Y-63.5%-29.0%2.2%

Return vs Industry: RNO underperformed the Australian Pharmaceuticals industry which returned -28.9% over the past year.

Return vs Market: RNO underperformed the Australian Market which returned 2.1% over the past year.

Price Volatility

Is RNO's price volatile compared to industry and market?
RNO volatility
RNO Average Weekly Movement11.4%
Pharmaceuticals Industry Average Movement9.5%
Market Average Movement8.5%
10% most volatile stocks in AU Market15.5%
10% least volatile stocks in AU Market3.4%

Stable Share Price: RNO is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: RNO's weekly volatility (11%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2004n/aMichael Johnsonhttps://www.rhinomed.global

Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. It offers wearable nasal technology that improve breathing, sleeping, and maintaining health and diagnose disease. The company’s products include Turbine for enhanced breathing in sports; Mute, which helps to breath more and snore less; Pronto, a vapor inhaler to improve airflow and better sleep; and Rhinoswab that is used to collect a nasal swab.

Rhinomed Limited Fundamentals Summary

How do Rhinomed's earnings and revenue compare to its market cap?
RNO fundamental statistics
Market CapAU$27.14m
Earnings (TTM)-AU$5.28m
Revenue (TTM)AU$9.61m

2.8x

P/S Ratio

-5.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
RNO income statement (TTM)
RevenueAU$9.61m
Cost of RevenueAU$2.90m
Gross ProfitAU$6.71m
Other ExpensesAU$11.99m
Earnings-AU$5.28m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.018
Gross Margin69.82%
Net Profit Margin-54.98%
Debt/Equity Ratio0%

How did RNO perform over the long term?

See historical performance and comparison